Sunday, December 4, 2022
HomeVenture Capital

Venture Capital

Venture Capital

Experic Closes $14 Million Series B Financing

Life Sciences Times - 0
Venture Capital

Charles River Associates (CRA) Acquires bioStrategies Group, Inc.

Life Sciences Times - 0
Venture Capital

Medical Informatics Corp. Raises $27 Million in Financing to Help Hospitals Manage Staff Shortages and Create New Standard of Data-driven Care

Life Sciences Times - 0
Venture Capital

AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy

Life Sciences Times - 0
Venture Capital

Strand Therapeutics Announces Series A1 Bringing Total Round to US$97 Million

Life Sciences Times - 0
Venture Capital

PayZen Raises $220 Million Growth Round for Personalized Healthcare Affordability

Life Sciences Times - 0
Venture Capital

Turbine Raises €20 Million in Series A Financing to Advance Programs & Partnerships Towards the Clinic with World’s First Cancer Cell Simulation Platform

Life Sciences Times - 0
Venture Capital

Ameresco Announces the Acquisition of Wind Farm in West County Cork, Ireland

Life Sciences Times - 0
Venture Capital

Healiva® Acquires Critical Cell Therapy Manufacturing Assets From B. Braun

Life Sciences Times - 0
Venture Capital

Merck to Acquire Imago BioSciences, Inc.

Life Sciences Times - 0
Venture Capital

FogPharma Announces $178 Million Series D Financing to Advance Pipeline of First-in-Class Helicon Polypeptide Therapeutics Targeting Major Cancer Drivers

Life Sciences Times - 0
Venture Capital

Opna Bio Launches with $38 Million Series A Financing to Advance Novel Oncology Discovery Program and Diversified Pipeline of Clinical and Preclinical Programs

Life Sciences Times - 0
123...57Page 1 of 57

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv